Abstract
Oxygen remains the first-line supportive therapy for hypoxemic patients with pneumothorax, yet its role in hastening pleural air re‑absorption is now recognised as modest and context‑dependent. This article synthesises 2025 guidance and recent literature to provide emergency physicians with a pragmatic, evidence‑based approach to oxygen use across primary spontaneous, secondary spontaneous, iatrogenic and traumatic pneumothorax.
1 | Introduction
Pneumothorax management in the emergency department (ED) centres on three imperatives: (1) rapid restoration of oxygenation; (2) prevention of tension physiology; and (3) definitive removal of intrapleural air when required. Decades of practice taught that high‑flow oxygen accelerates absorption via the nitrogen washout effect; however, modern data show that once an active leak remains—or when the leak is already small—clinical benefit beyond correcting hypoxemia is limited. Current guidelines therefore advocate a nuanced, type‑specific strategy rather than blanket high‑flow oxygen for every pneumothorax.
2 | Pathophysiology: The Nitrogen‑Washout Concept
Breathing FiO₂ ≈ 1.0 lowers alveolar nitrogen partial pressure from ~78 kPa to near 0 kPa, steepening the diffusion gradient for nitrogen to leave the pleural space. Northfield’s landmark experiment demonstrated a ~4‑fold faster radiographic shrinkage in volunteers given 100 % oxygen [3]. Although physiologically sound, this effect is increasingly outweighed in clinical practice by the size of the leak, patient stability and the logistics of prolonged high‑flow therapy.
3 | Evidence & Practice by Pneumothorax Type
3.1 Primary Spontaneous Pneumothorax (PSP)
Patient profile. Young, tall, otherwise healthy; bleb rupture.
Key evidence. 1971 Northfield study (17.9 cm² day⁻¹ vs 4.8 cm² day⁻¹) [3]; Park et al. 2017 found a ~2 × faster percentage‑shrinkage with low‑flow oxygen but < 48 h absolute difference for small PSP [4].
Guideline shift. BTS 2010 supported 15 L min⁻¹ oxygen during observation; BTS 2023 and the Franco‑multisociety 2023 consensus now advise no routine high‑flow oxygen in normoxic PSP [1].
ED algorithm.
- Small (<2 cm) & asymptomatic: observe on room air; supply low‑flow O₂ only if SpO₂ < 94 %.
- Moderate/large or symptomatic: aspirate or place small‑bore drain without delaying for oxygen.
- HFNC/NIV contra‑indicated unless a drain is in situ (risk of enlarging the leak).
3.2 Secondary Spontaneous Pneumothorax (SSP)
Patient profile. COPD, cystic fibrosis, ILD, necrotising infections.
Evidence. No trials support oxygen as monotherapy; small case series describe conservative O₂‑only management when drainage impossible.
Guideline consensus. Almost all SSPs warrant chest drainage; oxygen is supportive. Observation alone may be attempted only if first‑episode, <2 cm, completely stable [2].
ED algorithm.
- Initiate supplemental O₂; titrate to 88–92 % in CO₂ retainers.
- Insert chest tube or aspirate promptly unless criteria for rare conservative pathway are met.
- Avoid HFNC/NIV unless a tube is venting the pleural space.
3.3 Iatrogenic Pneumothorax (IPTX)
Scenario. Central venous catheter, transthoracic biopsy, thoracentesis, barotrauma.
Evidence. > 90 % of stable IPTX < 20 % resolve with O₂ + observation [5].
Practice.
- Provide low‑flow O₂; repeat CXR at 4–6 h.
- Discharge with 24‑h follow‑up if unchanged/shrinking.
- Drain if symptomatic, enlarging, or > 20 %.
3.4 Traumatic Pneumothorax
Scenario. Blunt/penetrating chest trauma; risk of tension with positive‑pressure ventilation (PPV).
Evidence. No RCTs show oxygen hastens resolution; benefit is purely supportive.
Guidelines. Western Trauma Association 2020: observe only if tiny (≤ 35 mm on CT or ≤ 1 cm CXR) and patient is not on PPV [6].
ED algorithm.
- Give high‑flow O₂ during initial resuscitation.
- Chest tube if any instability, PPV, or pneumothorax > minimal.
- Observe tiny PTX only in stable, self‑ventilating adults with serial imaging.
4 | Consolidated Decision Table
| Type | Oxygen Target | High‑Flow O₂ to Speed Absorption | Observe Without Drain | Drain Now If… |
|---|---|---|---|---|
| PSP | ≥ 94 % | Optional, not routine | < 2 cm & asymptomatic | > 2 cm, pain, dyspnea, failed aspiration |
| SSP | 88–92 % (COPD) | No; supportive only | Rare (< 2 cm, first event, stable) | Most cases |
| IPTX | ≥ 94 % | Yes for small (< 20 %) | Yes if small & asymptomatic | Symptomatic, enlarging, > 20 % |
| Trauma | ≥ 94 % | Unproven | Only if tiny & no PPV | Low threshold; always if on PPV |
5 | Bedside Pearls
- Correct hypoxemia immediately—do not await imaging.
- Skip routine high‑flow oxygen in normoxic PSP; benefit is trivial.
- Titrate FiO₂ carefully in COPD/SSP to avoid hypercapnic acidosis.
- Avoid HFNC/NIV without chest drainage—added pressure can worsen the leak.
- Provide clear discharge instructions and 24–48 h follow‑up for conservatively managed PSP/IPTX.
- Restrict air travel and altitude exposure until radiographic resolution.
6 | Controversies & Future Research
- High‑flow vs low‑flow oxygen in conservatively managed PSP: limited prospective data.
- Ambulatory oxygen devices: potential for outpatient therapy yet unstudied.
- Point‑of‑care ultrasound to quantify resolution speed under different FiO₂ settings warrants investigation.
7 | Conclusion
Oxygen is indispensable for hypoxemic pneumothorax patients but seldom decisive for resolution. Modern evidence discourages routine high‑flow O₂ in normoxic PSP and emphasises prompt pleural decompression in SSP and trauma. A tailored, physiology‑informed approach—balancing size, symptoms, leak dynamics and underlying lung reserve—optimises outcomes while avoiding unnecessary interventions.
8 | Reference :
Northfield TC. “Oxygen therapy for spontaneous pneumothorax.” Br Med J. 1971;4(5779):86–88.
- Landmark study showing ~3.7–4× faster reabsorption of pneumothorax with 100% O₂ versus room air
Park CB, Moon MH, Jeon HW, et al. “Does oxygen therapy increase the resolution rate of primary spontaneous pneumothorax?” J Thorac Dis. 2017;9(12):5239–5243.
- Retrospective study finding higher mean daily resolution rate (4.27% with O₂ vs 2.06% with room air), though clinical impact was modest
Grasmuk‑Siegl E, Valipour A. “‘Nitrogen Wash‑Out’ in Non‑Hypoxaemic Patients with Spontaneous Pneumothorax: A Narrative Review.” J Clin Med. 2023;12(13):4300.
- A comprehensive, recently published narrative review analyzing the nitrogen‑washout concept and re‑evaluating its utility in stable cases
High‑Flow Oxygen Therapy and Secondary Spontaneous Pneumothorax: A Case Report. Herald Open Access. 2024; article.
- A well‑documented case of successful conservative management (SSP) using high flow O₂ in a patient unsuitable for invasive intervention
Cheng HS. “Management of spontaneous pneumothorax: a mini‑review emphasizing recent developments.” J Thorac Dis. 2024;16(4):…
- This updated mini‑review focuses on current trends in PSP/SSP management and critically discusses the role of oxygen therapy
Lee J‑H, Kim R, Park CM. “Chest Tube Drainage Versus Conservative Management as the Initial Treatment of Primary Spontaneous Pneumothorax: A Systematic Review and Meta‑Analysis.” J Clin Med. 2020;9(11):3456.
- Meta‑analysis finding comparable resolution and recurrence rates for conservative vs invasive management, with fewer adverse events in the conservative group
